BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14555956)

  • 1. E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models.
    Wang Y; Hallden G; Hill R; Anand A; Liu TC; Francis J; Brooks G; Lemoine N; Kirn D
    Nat Biotechnol; 2003 Nov; 21(11):1328-35. PubMed ID: 14555956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linked tumor-selective virus replication and transgene expression from E3-containing oncolytic adenoviruses.
    Zhu M; Bristol JA; Xie Y; Mina M; Ji H; Forry-Schaudies S; Ennist DL
    J Virol; 2005 May; 79(9):5455-65. PubMed ID: 15827160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of the E3-6.7K/gp19K region reduces the persistence of wild-type adenovirus in a permissive tumor model in Syrian hamsters.
    Bortolanza S; Bunuales M; Alzuguren P; Lamas O; Aldabe R; Prieto J; Hernandez-Alcoceba R
    Cancer Gene Ther; 2009 Sep; 16(9):703-12. PubMed ID: 19229289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
    Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
    Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased apoptosis and reduced replication efficiency of the E3 region-modified dl309 adenovirus in cancer cells.
    Hibma MH; Real NC; Wiles A; Dobson-Le D; Dix BR; Wynford-Thomas D; Braithwaite AW; Royds JA
    Virus Res; 2009 Oct; 145(1):112-20. PubMed ID: 19576936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis.
    Yun CO; Kim E; Koo T; Kim H; Lee YS; Kim JH
    Cancer Gene Ther; 2005 Jan; 12(1):61-71. PubMed ID: 15375379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation increases the activity of oncolytic adenovirus cancer gene therapy vectors that overexpress the ADP (E3-11.6K) protein.
    Toth K; Tarakanova V; Doronin K; Ward P; Kuppuswamy M; Locke JE; Dawson JE; Kim HJ; Wold WS
    Cancer Gene Ther; 2003 Mar; 10(3):193-200. PubMed ID: 12637940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive visualization of adenovirus replication with a fluorescent reporter in the E3 region.
    Ono HA; Le LP; Davydova JG; Gavrikova T; Yamamoto M
    Cancer Res; 2005 Nov; 65(22):10154-8. PubMed ID: 16287998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity.
    Barton KN; Paielli D; Zhang Y; Koul S; Brown SL; Lu M; Seely J; Kim JH; Freytag SO
    Mol Ther; 2006 Feb; 13(2):347-56. PubMed ID: 16290236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus immunoregulatory E3 proteins prolong transplants of human cells in immunocompetent mice.
    Toth K; Doronin K; Kuppuswamy M; Ward P; Tollefson AE; Wold WS
    Virus Res; 2005 Mar; 108(1-2):149-59. PubMed ID: 15681065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-engineering adenovirus regulatory pathways to enhance oncolytic specificity and efficacy.
    Ramachandra M; Rahman A; Zou A; Vaillancourt M; Howe JA; Antelman D; Sugarman B; Demers GW; Engler H; Johnson D; Shabram P
    Nat Biotechnol; 2001 Nov; 19(11):1035-41. PubMed ID: 11689848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma.
    Lamfers ML; Gianni D; Tung CH; Idema S; Schagen FH; Carette JE; Quax PH; Van Beusechem VW; Vandertop WP; Dirven CM; Chiocca EA; Gerritsen WR
    Cancer Res; 2005 Oct; 65(20):9398-405. PubMed ID: 16230403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral coadministration of hyaluronidase enzyme and oncolytic adenoviruses enhances virus potency in metastatic tumor models.
    Ganesh S; Gonzalez-Edick M; Gibbons D; Van Roey M; Jooss K
    Clin Cancer Res; 2008 Jun; 14(12):3933-41. PubMed ID: 18559615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
    Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
    Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
    Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy.
    Kim JH; Lee YS; Kim H; Huang JH; Yoon AR; Yun CO
    J Natl Cancer Inst; 2006 Oct; 98(20):1482-93. PubMed ID: 17047197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo.
    Rivera AA; Wang M; Suzuki K; Uil TG; Krasnykh V; Curiel DT; Nettelbeck DM
    Virology; 2004 Mar; 320(1):121-34. PubMed ID: 15003868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity.
    Kirby TO; Rivera A; Rein D; Wang M; Ulasov I; Breidenbach M; Kataram M; Contreras JL; Krumdieck C; Yamamoto M; Rots MG; Haisma HJ; Alvarez RD; Mahasreshti PJ; Curiel DT
    Clin Cancer Res; 2004 Dec; 10(24):8697-703. PubMed ID: 15623655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice.
    Ganesh S; Gonzalez Edick M; Idamakanti N; Abramova M; Vanroey M; Robinson M; Yun CO; Jooss K
    Cancer Res; 2007 May; 67(9):4399-407. PubMed ID: 17483354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.
    Thomas MA; Spencer JF; La Regina MC; Dhar D; Tollefson AE; Toth K; Wold WS
    Cancer Res; 2006 Feb; 66(3):1270-6. PubMed ID: 16452178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.